Literature DB >> 12605306

Transport of organic anions across the basolateral membrane of proximal tubule cells.

B C Burckhardt1, G Burckhardt.   

Abstract

Renal proximal tubules secrete diverse organic anions (OA) including widely prescribed anionic drugs. Here, we review the molecular properties of cloned transporters involved in uptake of OA from blood into proximal tubule cells and provide extensive lists of substrates handled by these transport systems. Where tested, transporters have been immunolocalized to the basolateral cell membrane. The sulfate anion transporter 1 (sat-1) cloned from human, rat and mouse, transported oxalate and sulfate. Drugs found earlier to interact with sulfate transport in vivo have not yet been tested with sat-1. The Na(+)-dicarboxylate cotransporter 3 (NaDC-3) was cloned from human, rat, mouse and flounder, and transported three Na(+) with one divalent di- or tricarboxylate, such as citric acid cycle intermediates and the heavy metal chelator 2,3-dimercaptosuccinate (succimer). The organic anion transporter 1 (OAT1) cloned from several species was shown to exchange extracellular OA against intracellular alpha-ketoglutarate. OAT1 translocated, e.g., anti-inflammatory drugs, antiviral drugs, beta-lactam antibiotics, loop diuretics, ochratoxin A, and p-aminohippurate. Several OA, including probenecid, inhibited OAT1. Human, rat and mouse OAT2 transported selected anti-inflammatory and antiviral drugs, methotrexate, ochratoxin A, and, with high affinities, prostaglandins E(2) and F(2alpha). OAT3 cloned from human, rat and mouse showed a substrate specificity overlapping with that of OAT1. In addition, OAT3 interacted with sulfated steroid hormones such as estrone-3-sulfate. The driving forces for OAT2 and OAT3, the relative contributions of all OA transporters to, and the impact of transporter regulation by protein kinases on renal drug excretion in vivo must be determined in future experiments.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12605306     DOI: 10.1007/s10254-002-0003-8

Source DB:  PubMed          Journal:  Rev Physiol Biochem Pharmacol        ISSN: 0303-4240            Impact factor:   5.545


  82 in total

1.  Organic anion transporter 3 (OAT3) and renal transport of the metal chelator 2,3-dimercapto-1-propanesulfonic acid (DMPS).

Authors:  Matthias Rödiger; Xiaohong Zhang; Bernhard Ugele; Nikolaus Gersdorff; Stephen H Wright; Gerhard Burckhardt; Andrew Bahn
Journal:  Can J Physiol Pharmacol       Date:  2010-02       Impact factor: 2.273

Review 2.  Roles of organic anion transporters (OATs) and a urate transporter (URAT1) in the pathophysiology of human disease.

Authors:  Atsushi Enomoto; Hitoshi Endou
Journal:  Clin Exp Nephrol       Date:  2005-09       Impact factor: 2.801

Review 3.  Organic anion transporters of the SLC22 family: biopharmaceutical, physiological, and pathological roles.

Authors:  Ahsan N Rizwan; Gerhard Burckhardt
Journal:  Pharm Res       Date:  2007-03       Impact factor: 4.200

4.  Functional maturation of drug transporters in the developing, neonatal, and postnatal kidney.

Authors:  Derina E Sweeney; Volker Vallon; Timo Rieg; Wei Wu; Thomas F Gallegos; Sanjay K Nigam
Journal:  Mol Pharmacol       Date:  2011-04-14       Impact factor: 4.436

5.  Linkage of organic anion transporter-1 to metabolic pathways through integrated "omics"-driven network and functional analysis.

Authors:  Sun-Young Ahn; Neema Jamshidi; Monica L Mo; Wei Wu; Satish A Eraly; Ankur Dnyanmote; Kevin T Bush; Tom F Gallegos; Douglas H Sweet; Bernhard Ø Palsson; Sanjay K Nigam
Journal:  J Biol Chem       Date:  2011-07-12       Impact factor: 5.157

6.  Structural variation governs substrate specificity for organic anion transporter (OAT) homologs. Potential remote sensing by OAT family members.

Authors:  Gregory Kaler; David M Truong; Akash Khandelwal; Megha Nagle; Satish A Eraly; Peter W Swaan; Sanjay K Nigam
Journal:  J Biol Chem       Date:  2007-06-05       Impact factor: 5.157

7.  Sex-dependent expression of Oat3 (Slc22a8) and Oat1 (Slc22a6) proteins in murine kidneys.

Authors:  Davorka Breljak; Hrvoje Brzica; Douglas H Sweet; Naohiko Anzai; Ivan Sabolic
Journal:  Am J Physiol Renal Physiol       Date:  2013-02-06

Review 8.  Emerging Kidney Models to Investigate Metabolism, Transport, and Toxicity of Drugs and Xenobiotics.

Authors:  Piyush Bajaj; Swapan K Chowdhury; Robert Yucha; Edward J Kelly; Guangqing Xiao
Journal:  Drug Metab Dispos       Date:  2018-08-03       Impact factor: 3.922

Review 9.  Toward a systems level understanding of organic anion and other multispecific drug transporters: a remote sensing and signaling hypothesis.

Authors:  Sun-Young Ahn; Sanjay K Nigam
Journal:  Mol Pharmacol       Date:  2009-06-10       Impact factor: 4.436

10.  Discovery of potent, selective multidrug and toxin extrusion transporter 1 (MATE1, SLC47A1) inhibitors through prescription drug profiling and computational modeling.

Authors:  Matthias B Wittwer; Arik A Zur; Natalia Khuri; Yasuto Kido; Alan Kosaka; Xuexiang Zhang; Kari M Morrissey; Andrej Sali; Yong Huang; Kathleen M Giacomini
Journal:  J Med Chem       Date:  2013-01-22       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.